Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “HER-2 Positive Malignant Carcinoma of Breast”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT02252887
What this trial is testing

Gemcitabine, Trastuzumab, and Pertuzumab in the Treatment of Metastatic HER2-Positive Breast Cancer After Prior Trastuzumab/Pertuzumab, or Pertuzumab Based Therapy

Who this might be right for
Metastatic HER2-Positive Breast Cancer
Memorial Sloan Kettering Cancer Center 45
Early research (Phase 1)Study completedNCT02135159
What this trial is testing

Patients With Brain Metastases From HER2-positive Breast Cancer

Who this might be right for
HER2-positive Breast Cancer
Institut du Cancer de Montpellier - Val d'Aurelle 36
Testing effectiveness (Phase 2)Study completedNCT04276493
What this trial is testing

Anti-HER2 Bispecific Antibody Zanidatamab (ZW25) Activity in Combination With Chemotherapy With/Without Tislelizumab

Who this might be right for
Breast CancerGastric CancerGastroesophageal Junction Cancer
BeiGene 71
Early research (Phase 1)Temporarily pausedNCT04650451
What this trial is testing

Safety and Activity Study of HER2-Targeted Dual Switch CAR-T Cells (BPX-603) in Subjects With HER2-Positive Solid Tumors

Who this might be right for
HER-2 Gene AmplificationHER2-positive Gastric CancerHER2-positive Breast Cancer+2 more
Bellicum Pharmaceuticals 220
Large-scale testing (Phase 3)Looking for participantsNCT07413939
What this trial is testing

RO7771950 Versus Tucatinib in Combination With Trastuzumab and Capecitabine in People With Locally Advanced or Metastatic Breast Cancer That is Human Epidermal Growth Factor Receptor 2 (HER2)-Positive

Who this might be right for
HER2-positive Breast Cancer
Hoffmann-La Roche 650
Early research (Phase 1)Ended earlyNCT01705340
What this trial is testing

Akt Inhibitor MK2206, Lapatinib Ditosylate, and Trastuzumab in Treating Patients With Locally Advanced or Metastatic HER2-Positive Breast , Gastric, or Gastroesophageal Cancer That Cannot Be Removed By Surgery

Who this might be right for
Adenocarcinoma of the Gastroesophageal JunctionHER2-positive Breast CancerMale Breast Cancer+9 more
National Cancer Institute (NCI) 60
Not applicableStudy completedNCT05149014
What this trial is testing

Safety, Effectiveness and Quality of Life of Trastuzumab Deruxtecan in Patients with HER2+ Breast Cancer

Who this might be right for
HER2-positive Breast Cancer
Daiichi Sankyo France 306
Not applicableActive Not RecruitingNCT05955521
What this trial is testing

Exosome as the Prognostic and Predictive Biomarker in EBC Patients

Who this might be right for
Triple Negative Breast CancerHER2-positive Breast Cancer
Samsung Medical Center 200
Testing effectiveness (Phase 2)Ended earlyNCT03248492
What this trial is testing

DS-8201a in Metastatic Breast Cancer Previously Treated With Trastuzumab Emtansine (T-DM1)

Who this might be right for
Breast Cancer
Daiichi Sankyo 253
Testing effectiveness (Phase 2)Ended earlyNCT05954143
What this trial is testing

Trial of BDC-1001 +/- Pertuzumab in Subjects With HER2-Positive Metastatic Breast Cancer

Who this might be right for
Metastatic Breast CancerHER2-positive Breast Cancer
Bolt Biotherapeutics, Inc. 11
Large-scale testing (Phase 3)Active Not RecruitingNCT02947685
What this trial is testing

Randomized, Open Label, Clinical Study of the Targeted Therapy, Palbociclib, to Treat Metastatic Breast Cancer

Who this might be right for
HER-2 Positive Breast CancerEstrogen Receptor Positive Breast Cancer
Alliance Foundation Trials, LLC. 518
Large-scale testing (Phase 3)Study completedNCT03013504
What this trial is testing

A Phase III Trial to Compare the Efficacy, Safety and Pharmacokinetics of HD201 to Herceptin® in HER2+ Early Breast Cancer Patients

Who this might be right for
HER2 Positive Breast Cancer
Prestige Biopharma Limited 503
Testing effectiveness (Phase 2)Study completedNCT00847171
What this trial is testing

Trastuzumab, Cyclophosphamide, and Vaccine Therapy in Treating Patients With High-Risk or Metastatic Breast Cancer

Who this might be right for
Breast Cancer
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 20
Not applicableLooking for participantsNCT06892093
What this trial is testing

Probiotics for Prevention of Neratinib-Induced Diarrhea in Breast Cancer Patients

Who this might be right for
HER2-positive Breast CancerDiarrhea Caused by DrugNeratinib
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University 308
Not applicableWithdrawnNCT07136493
What this trial is testing

Circulating Tumor DNA Based Minimal Residual Disease Detection for Patients With Early-Stage Breast Cancer

Who this might be right for
Anatomic Stage I Breast Cancer AJCC v8Anatomic Stage II Breast Cancer AJCC v8Anatomic Stage III Breast Cancer AJCC v8+4 more
City of Hope Medical Center
Testing effectiveness (Phase 2)WithdrawnNCT03326258
What this trial is testing

Glembatumumab Vedotin, Nivolumab, and Ipilimumab in Treating Patients With Advanced Metastatic Solid Tumors That Cannot Be Removed by Surgery

Who this might be right for
Advanced Malignant Solid NeoplasmEstrogen Receptor NegativeGPNMB Positive+15 more
National Cancer Institute (NCI)
Testing effectiveness (Phase 2)Study completedNCT00717405
What this trial is testing

Avastin (Bevacizumab) Plus Herceptin (Trastuzumab) in Patients With Primary Inflammatory HER2-Positive Breast Cancer.

Who this might be right for
Breast Cancer
Hoffmann-La Roche 52
Testing effectiveness (Phase 2)Study completedNCT02675231
What this trial is testing

Abemaciclib (LY2835219) in Women With HR+, HER2+ Locally Advanced or Metastatic Breast Cancer

Who this might be right for
Hormone Receptor Positive Breast CancerHER-2 Positive Breast Cancer
Eli Lilly and Company 237
Testing effectiveness (Phase 2)WithdrawnNCT01163929
What this trial is testing

Look at the Combination of Chemotherapy, Trastuzumab and RAD001 in HER2 Positive Breast Cancer

Who this might be right for
Breast Cancer
University of Kansas
Testing effectiveness (Phase 2)Looking for participantsNCT07635342
What this trial is testing

Pyrotinib Plus Trastuzumab and Chemotherapy for HER2-Positive Early Breast Cancer

Who this might be right for
HER2-positive Breast Cancer
Hebei Medical University Fourth Hospital 182
Next Page